<bill session="115" type="h" number="5582" updated="2019-04-18T16:22:44Z">
  <state datetime="2018-06-12T17:16:15-04:00">PASS_OVER:HOUSE</state>
  <status>
    <unknown datetime="2018-06-12T17:16:15-04:00"/>
  </status>
  <introduced datetime="2018-04-23"/>
  <titles>
    <title type="official" as="introduced">To direct the Secretary of Health and Human Services to conduct a study and submit a report on barriers to accessing abuse-deterrent opioid formulations for individuals enrolled in a plan under part C or D of the Medicare program.</title>
    <title type="short" as="passed house">Abuse Deterrent Access Act of 2018</title>
    <title type="short" as="reported to house">Abuse Deterrent Access Act of 2018</title>
    <title type="short" as="introduced">Abuse Deterrent Access Act of 2018</title>
    <title type="display">Abuse Deterrent Access Act of 2018</title>
  </titles>
  <sponsor bioguide_id="C001103"/>
  <cosponsors>
    <cosponsor bioguide_id="B001243" joined="2018-05-11"/>
    <cosponsor bioguide_id="D000482" joined="2018-04-24"/>
    <cosponsor bioguide_id="L000565" joined="2018-04-23"/>
    <cosponsor bioguide_id="M001156" joined="2018-05-11"/>
    <cosponsor bioguide_id="R000585" joined="2018-04-23"/>
    <cosponsor bioguide_id="W000791" joined="2018-05-11"/>
  </cosponsors>
  <actions>
    <action datetime="2018-04-23">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-04-23" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-04-23">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-05-01">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2018-05-09">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <calendar datetime="2018-05-09" state="REPORTED">
      <text>Ordered to be Reported (Amended) by Voice Vote.</text>
    </calendar>
    <action datetime="2018-06-08">
      <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-721, Part I.</text>
    </action>
    <action datetime="2018-06-08">
      <text>Committee on Ways and Means discharged.</text>
    </action>
    <calendar datetime="2018-06-08" calendar="Union" number="556">
      <text>Placed on the Union Calendar, Calendar No. 556.</text>
    </calendar>
    <action datetime="2018-06-12T17:09:59-04:00">
      <text>Mr. Walden moved to suspend the rules and pass the bill, as amended.</text>
    </action>
    <action datetime="2018-06-12T17:10:11-04:00">
      <text>Considered under suspension of the rules.</text>
      <reference ref="CR H5061-5063" label="consideration"/>
    </action>
    <action datetime="2018-06-12T17:10:13-04:00">
      <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 5582.</text>
    </action>
    <vote how="by voice vote" type="vote" datetime="2018-06-12T17:16:15-04:00" where="h" result="pass" state="PASS_OVER:HOUSE">
      <text>On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.</text>
      <reference ref="CR H5061" label="text"/>
    </vote>
    <action datetime="2018-06-12T17:16:17-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2018-06-13">
      <text>Received in the Senate and Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSFI" name="Senate Finance" activity="Referral"/>
    <committee subcommittee="" code="HSWM" name="House Ways and Means" activity="Discharged, Referral"/>
    <committee subcommittee="Health" code="HSWM02" name="House Ways and Means" activity="Referral"/>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="115" relation="unknown" number="6"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Drug therapy"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Government studies and investigations"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care coverage and access"/>
    <term name="Health promotion and preventive care"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2018-06-12T13:10:00Z" status="Passed House amended">Abuse Deterrent Access Act of 2018

(Sec. 2) This bill requires the Centers for Medicare &amp; Medicaid Services to report to Congress on the adequacy of access to abuse-deterrent opioid formulations for individuals with chronic pain enrolled in&#160;a&#160;prescription drug plan under Medicare or Medicare Advantage (MA). The report&#160;must account for&#160;any barriers preventing enrollees from accessing such formulations under Medicare or MA.</summary>
  <committee-reports>
    <report>H. Rept. 115-721</report>
  </committee-reports>
</bill>
